QC
NVO

Quent Capital’s Novo Nordisk NVO Stock Holding History

Quent Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.1K Buy
774
+48
+7% +$2.06K ﹤0.01% 894
2026
Q1 		$26.7K Sell
726
-144
-17% -$6.82K ﹤0.01% 904
2025
Q4 		$44.3K Buy
870
+144
+20% +$7.36K ﹤0.01% 778
2025
Q3 		$40.3K Buy
+726
New +$42.5K ﹤0.01% 663
2025
Q2 		– Sell
-726
Closed -$50.4K – 929
2025
Q1 		$50.4K Hold
726
– – 0.01% 559
2024
Q4 		$62.5K Buy
+726
New +$78.5K 0.01% 529

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quent Capital's NVO Position: Q2 2026 in Review

Quent Capital increased its Novo Nordisk (NVO) stake by 6.6% in Q2 2026, buying an estimated $2.06K and bringing the position to 774 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Quent Capital first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $62.5K in Q4 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Quent Capital held 774 shares of Novo Nordisk worth $37.1K as of Q2 2026.
  • Quent Capital bought 48 Novo Nordisk shares in Q2 2026, an estimated $2.06K.
  • Novo Nordisk made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #894 holding.
  • Quent Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Quent Capital's Novo Nordisk position peaked at $62.5K in Q4 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.